Amgen VP of Investor Relations Arvind Sood to Present at the Baird Growth Stock Conference
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--May 13, 2008--Amgen
(NASDAQ:AMGN) Vice President of Investor Relations Arvind Sood will
present at the RW Baird Growth Stock Conference on Wednesday, May 14,
2008 beginning at 8:55 a.m. Central Time. Live audio of the
presentation will be available over the Internet and can be accessed
from Amgen's Web site, www.amgen.com, under Investors.
Information regarding presentation time, webcast availability, and
webcast links are noted on Amgen's Investor Relations Events Calendar.
Amgen discovers, develops, manufactures and delivers innovative
human therapeutics. A biotechnology pioneer since 1980, Amgen was one
of the first companies to realize the new science's promise by
bringing safe and effective medicines from lab, to manufacturing
plant, to patient. Amgen therapeutics have changed the practice of
medicine, helping millions of people around the world in the fight
against cancer, kidney disease, rheumatoid arthritis, and other
serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to
dramatically improve people's lives. To learn more about our
pioneering science and our vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks
David Polk, 805-447-4613 (media)
Cory Rivera, 805-447-1060 (investors)